The FDA is investigating why Fresenius Medical Care did not warn all dialysis centers that its product, GranuFlo, could cause cardiac arrest when used improperly.
Improper use of GranuFlo during dialysis could increase a patient’s risk of cardiac arrest by four to six times. The discovery prompted Fresenius Medical Care (FMC), maker of GranuFlo, to send a memo warning doctors at its nationwide centers. However, the FDA is investigating why Fresenius did not send a similar memo to other centers that use its product until five months later, and if this delay could have injured patients.
Thomas J. Henry is a personal injury law firm with offices in Corpus Christi, Texas and Houston, Texas representing accident victims nationwide. Our priority is to provide our clients with the best legal representation. Our experienced trial attorneys are committed to defending your rights in personal injury matters including defective products, recalled drugs, child injuries, and auto accidents.